• gmp-verlag.de
  • GMP MANUAL Login
  • Shopping cart
Stay informed!

If you’d like to be regularly informed of the latest developments at Good Manufacturing Practices

 

>>> REGISTER for our free GMP Newsletter LOGFILE

Image

TOP 5 GMP Downloads

1. GDP Audit Checklist
More than 700 questions with reference to regulations for preparing and carrying out GDP audits.

 

2. GMP Audit Checklist
The GMP Audit Checklist works great for both sides - the auditor and the inspected company.

 

3. Quality Agreement
Defines framework conditions and processes between contract givers and contract acceptors in order to meet mandatory quality criteria.

 

4. Risk Management
Apart from factual content you will find many tables, examples, forms, which can be used in daily practice.

 

5. Documenting Process Validation – A Drugmaker’s Guide
Document process validation in a way that’s sure to satisfy – and impress – regulators.

 

Your benefits:

> no shipping costs
> no waiting period: if you choose payment by credit card you will receive an email with the download information immediately after payment.

 

>>> Click here to find more Downloads!

News about GMP/cGMP

2012-01-05

EMA: Work Plan 2012

The European Medicines Agency (EMA) released the work programme for 2012.

 

In 2012 the Agency will focus on the following topics:

  • Implementing new pharmacovigilance legislation
  • Implementing revised policies on handling conflicts on interests
  • Ethical and practical GCP (Good Clinical Practice) aspects of clinical trials
  • Progress of Agency interactions with healthcare professionals
  • Supply shortages of medicines caused by insufficient GMP compliance. EMAs Management Board initiated the discussion on a "Reflection paper on medicinal product supply shortages caused by manufacturing/GMP compliance problems".
Outcome:

EMA will publish a detailled work plan in January 2012. The "Reflection paper on ethical and GCP aspects of clinical trials of medicinal products for human use conducted outside of the EU/EEA and submitted in marketing authorisation applications to the EU regulatory authorities" will be presented to the Heads of Medicines Agencies for endorsement in February 2012 as a final step.

Source:

EMA/ Announcement

 

Comments
No comment has yet been written about this news.